Effect of folic acid on nitrate tolerance in healthy volunteers: Differences between arterial and venous circulation

Journal of Cardiovascular Pharmacology

Volumn 41, Issue 2, 2003, Pages 185-190

  Gori, Tommaso ^a   Saunders, Laura ^a   Ahmed, Sofia ^a   Parker, John D ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; GLYCERYL TRINITRATE; NITRATE;

ADULT; ARTERIAL CIRCULATION; ARTERY BLOOD FLOW; ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; VEIN BLOOD FLOW; VENOUS CIRCULATION;

ADULT; ANALYSIS OF VARIANCE; ARTERIES; BLOOD PRESSURE; DOUBLE-BLIND METHOD; DRUG TOLERANCE; FOLIC ACID; FOREARM; HEART RATE; HUMANS; MALE; NITRATES; NITROGLYCERIN; VEINS;

EID: 0037307813     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200302000-00006     Document Type: Article

References (23)

1. Parker JD, Parker JO. Nitrate therapy for stable angina pectoris. N Engl J Med. 1998;338:520-31.
2. Münzel T, Sayegh H, Freeman BA, et al. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: a novel mechanism underlying tolerance and cross-tolerance. J Clin Invest. 1995;95:187-94.
3. Münzel T, Kurz S, Rajagopalan S, et al. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: a new action for an old drug. J Clin Invest. 1996;98:1465-70.
4. Münzel T, Li H, Mollnau H, et al. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability. Circ Res. 2000;86:E7-12.
5. Caramori PR, Adelman AG, Azevedo ER, et al. Therapy with nitroglycerin increases coronary vasoconstriction in response to acetylcholine. J Am Coll Cardiol. 1998;32:1969-74.
6. Gori T, Mak SS, Kelly S, et al. Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humans. J Am Coll Cardiol. 2001;38:1096-101.
7. Schulz E, Tsilimingas N, Rinze R, et al. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Circulation. 2002;105:1170-5.
8. Leier CV, Huss P, Magorien RD, et al. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation. 1983;67:817-22.
9. Ghio S, de Servi S, Perotti R, et al. Different susceptibility to the development of nitroglycerin tolerance in the arterial and venous circulation in humans: effects of N-acetylcysteine administration. Circulation. 1992;86:798-802.
10. Stewart DJ, Elsner D, Sommer O, et al. Altered spectrum of nitroglycerin action in long-term treatment: nitroglycerin-specific venous tolerance with maintenance of arterial vasodepressor potency. Circulation. 1986;74:573-82.
11. Gori T, Burstein J, Ahmed S, et al. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study. Circulation. 2001;104:1119-23.
12. Milone SD, Pace-Asciak CR, Reynaud D, et al. The angiotensin II-receptor antagonist losartan does not prevent hemodynamic or vascular tolerance to nitroglycerin. J Cardiovasc Pharmacol. 1999;34:645-50.
13. Kaesemeyer WH, Ogonowski AA, Jin L, et al. Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate. Br J Pharmacol. 2000;131:1019-23.
14. Abou-Mohamed G, Kaesemeyer WH, Caldwell RB, et al. Role of L-arginine in the vascular actions and development of tolerance to nitroglycerin. Br J Pharmacol. 2000;130:211-8.
15. Berkenboom G, Fontaine D, Unger P. et al. Absence of nitrate tolerance after long-term treatment with ramipril: an endothelium-dependent mechanism. J Cardiovasc Pharmacol. 1999;34:547-53.
16. Wilmink HW, Stroes ES, Erkelens WD, et al. Influence of folic acid on postprandial endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2000;20:185-8.
17. Loscalzo J. Folate and nitrate-induced endothelial dysfunction: a simple treatment for a complex pathobiology. Circulation. 2001;104:1086-8.
18. Cosentino F, Luscher TF. Tetrahydrobiopterin and endothelial nitric oxide synthase activity. Cardiovasc Res. 1999;43:274-8.
19. Gruhn N, Aldershvile J, Boesgaard S. Tetrahydrobiopterin improves endothelium-dependent vasodilation in nitroglycerin-tolerant rats. Eur J Pharmacol. 2001;416:245-9.
20. Wang EQ, Lee W-I, Fung H-L. Lack of critical involvement of endothelial nitric oxide synthase in vascular nitrate tolerance in mice. Br J Pharmacol. 2002;135:299-302.
21. Zelis R, Mason DT. Isosorbide dinitrate: effect on the vasodilator response to nitroglycerin. JAMA. 1975;234:166-70.
22. De Garavilla L, Pagani ED, Buchholz RA, et al. Zaprinast, but not dipyridamole, reverses hemodynamic tolerance to nitroglycerin in vivo. Eur J Pharmacol. 1996;313:89-96.
23. Münzel T. Holtz J, Mulsch A, et al. Nitrate tolerance in epicardial arteries or in the venous system is not reversed by N-acetylcysteine in vivo, but tolerance-independent interactions exist. Circulation. 1989;79:188-97.